Kevin Kalinsky, MD, MS Winship Cancer Institute Associate Professor of Hematology and Medical Oncology, Emory University School of Medicine, Chair of the Louisa and Lund Gren...
The addition of tucatinib to the maintenance of standard of care in the first-line setting of patients with HER2-positive metastatic breast cancer will be considered in...
Professor of Funmi Olopade, MD, FACP, Medicine and Human Genetics, and Founding Director of Clinical Cancer Genetics and Global Health Center at the University of Chicago...
Recent Comments